TGA surveys stakeholders on compliance priorities for FY24 by Martin Lane March 27, 2023April 30, 2024 The Therapeutic Goods Administration (TGA) has launched a stakeholder survey to help inform its compliance activities […]
A single code of conduct would help rid the industry of bad actors by Martin Lane March 23, 2023April 30, 2024
TGA warns of ‘across-the-board’ sanctions if products fail to meet GMP quality requirements by Steve Jones March 16, 2023April 30, 2024
Bod CEO ‘confident’ firm will register over-the-counter CBD medicine as insomnia trial progresses by Martin Lane March 13, 2023April 30, 2024
Montu rejects ‘hijack’ claim as row erupts over awareness week website by Steve Jones February 23, 2023April 30, 2024
Dob-in website launches to report ‘unethical’ practices in the medicinal cannabis space by Martin Lane February 23, 2023January 13, 2025
Shelf-life claims on TGA radar as industry warned of widespread consequences by Steve Jones February 9, 2023February 9, 2023
Industry pays tribute as TGA boss John Skerritt announces retirement by Martin Lane February 3, 2023April 29, 2024
Concerns mount over non-GMP dump in local market as reform date nears by Steve Jones February 2, 2023February 3, 2023
SAS-B approvals dip in 2022 following TGA reforms, but patient numbers still climbing by Martin Lane January 9, 2023April 29, 2024